• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Toshiba, Japanese QST tout heavy-ion therapy breakthrough

Toshiba, Japanese QST tout heavy-ion therapy breakthrough

May 10, 2017 By Fink Densford

Toshiba

Toshiba (TYO:6502) said today that it, along with Japan’s National Institutes for Quantum and Radiological Science and Technology have developed a novel pencil beaming scanning system which they claim significantly reduces the size of the system without lowered performance.

The company said that the newly designed system can be mounted on a rotating gantry with superconducing beam bending magnets, which will lead to further downsizing and weight reductions.

Toshiba said it will release more details of the device this week at the 56th Annual COnference of the Particle Therapy Co-operation group in Yokohama.

“Toshiba has already led the way in applying advanced expertise in superconductivity to downsizing the rotating gantry, but we recognized that even further size reduction is necessary for wider adoption of heavy-ion therapy systems. With our colleagues at the National Institute of Radiological Sciences, we have now realized a rotating gantry that is more affordable for customers around the world. I am happy that the fusion of QST-NIRS’ world-class clinical knowledge in heavy-ion therapy and Toshiba’s wide-ranging industrial technologies is opening up highly promising new possibilities in cancer treatment,” Toshiba corp new technology project engineering dept. senior manager Yutaka Hirata said in a prepared statement.

The new system is designed to optimize the performance of the systems’ electromangets by tapering their shape for a wider duct at the downstream end. Toshiba claims that the tapering ensures the spread of the carbon-ion beam to create a pencil beam and effective achievement of the irradiation field.

“The QST-NIRS-Toshiba collaboration team has successfully developed a state-of-the-art scanning irradiation system. This development substantially downsizes the system while keeping its performance. I believe that, thanks to this novel device, each and every heavy-ion therapy facility will be able to have a rotating gantry, making it the de facto standard. I need to emphasize that this technology is also applicable to proton therapy systems. This technology is a breakthrough for particle therapy,” QST-NIRS advanced particle therapy system research team lead Dr. Takuji Furukawa said in a press release.

Filed Under: Oncology, Research & Development Tagged With: Toshiba

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy